The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients

Biosci Rep. 2017 Jun 8;37(3):BSR20170213. doi: 10.1042/BSR20170213. Print 2017 Jun 30.

Abstract

Advanced glycation end-products (AGEs), measured by skin autofluorescence (AF), are a factor in the development or worsening of many degenerative diseases, such as diabetes and atherosclerosis. Irisin levels have been associated with diabetes, endothelial dysfunction and atherosclerosis. The objective of the present study was to investigate whether circulating irisin levels are correlated with skin AF values in type 2 diabetes patients. A total of 362 Chinese type 2 diabetic patients and 100 age- and sex-matched healthy controls were recruited in the present study. Clinical characteristics, blood biochemistry and circulating irisin levels were measured. Skin AF was measured using an AGE reader. Circulating irisin levels were significantly lower, while skin AF values were increased in type 2 diabetes compared with controls (P<0.05 respectively). By dividing the distribution of skin AF values into tertiles, serum irisin levels gradually lowered with increasing skin AF values (P<0.05). After adjusting for covariates, multivariate stepwise regression analysis demonstrated that serum lower irisin levels were independently associated with skin AF (P=0.009). Circulating irisin levels were lower in type 2 diabetes patients compared with healthy controls. Lower levels of irisin are independently associated with elevated skin AF values, indicating that circulating irisin levels could be associated with AGEs accumulation, which is one of the reasons causing vascular complications in diabetic patients.

Keywords: advanced glycation end products; endothelial dysfunction; irisin.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Asian Continental Ancestry Group
  • China
  • Diabetes Mellitus, Type 2* / blood
  • Diabetes Mellitus, Type 2* / diagnostic imaging
  • Diabetes Mellitus, Type 2* / pathology
  • Diabetic Angiopathies* / blood
  • Diabetic Angiopathies* / diagnostic imaging
  • Diabetic Angiopathies* / pathology
  • Female
  • Fibronectins / blood*
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Optical Imaging*
  • Skin* / diagnostic imaging
  • Skin* / metabolism

Substances

  • FNDC5 protein, human
  • Fibronectins
  • Glycation End Products, Advanced